S. Reed - Jan 28, 2025 Form 4 Insider Report for Evoke Pharma Inc (EVOK)

Role
Director
Signature
/s/ Matthew J. D'Onofrio, Attorney-in-fact for Vicke S. Reed
Stock symbol
EVOK
Transactions as of
Jan 28, 2025
Transactions value $
$0
Form type
4
Date filed
1/29/2025, 04:30 PM
Previous filing
May 24, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVOK Stock Option (Right to Buy) Award $0 +5.83K $0.00 5.83K Jan 28, 2025 Common Stock 5.83K $4.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The total number of shares of common stock subject to the option shall vest one-third of the total number of shares each one-year period after the vesting commencement date, so that the option shall be fully vested on the third anniversary of the vesting commencement date, subject to the Holder's continued service to the Company through each such vesting date.